Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Sabbagh

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Acta Neurologica Scandinavica. Supplementum|July 27, 2006
Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trialD L Sparks, D J Connor, M N Sabbagh, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1997
Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's diseaseM N Sabbagh, P Lynn, S Jhingran, et al.
Neurology|July 1, 1997
The impact of apolipoprotein E4 on cause of death in Alzheimer's diseaseJ M Olichney, M N Sabbagh, C R Hofstetter, et al.
Parkinsonism & Related Disorders|May 12, 2005
Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?M N Sabbagh, N Silverberg, S Bircea, et al.
Neurology|January 1, 1997
Hippocampal sclerosis contributes to dementia in the elderlyJ Corey-Bloom, M N Sabbagh, M W Bondi, et al.
Neurology|February 11, 2000
E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's diseaseJ Corey-Bloom, P Tiraboschi, L A Hansen, et al.
Neurology|February 11, 2000
Cholinergic dysfunction in diseases with Lewy bodiesP Tiraboschi, L A Hansen, M Alford, et al.
Neurology|April 17, 2008
Pathologic findings in prospectively ascertained essential tremor subjectsH A Shill, C H Adler, M N Sabbagh, et al.
Neurology|April 13, 2005
Smoking affects the phenotype of Alzheimer diseaseM N Sabbagh, S L Tyas, S C Emery, et al.
Dementia and Geriatric Cognitive Disorders|July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's diseaseC G Schipke, O Peters, I Heuser, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Acta Neurologica Scandinavica. Supplementum|July 27, 2006
Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trialD L Sparks, D J Connor, M N Sabbagh, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1997
Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's diseaseM N Sabbagh, P Lynn, S Jhingran, et al.
Neurology|July 1, 1997
The impact of apolipoprotein E4 on cause of death in Alzheimer's diseaseJ M Olichney, M N Sabbagh, C R Hofstetter, et al.
Parkinsonism & Related Disorders|May 12, 2005
Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?M N Sabbagh, N Silverberg, S Bircea, et al.
Neurology|January 1, 1997
Hippocampal sclerosis contributes to dementia in the elderlyJ Corey-Bloom, M N Sabbagh, M W Bondi, et al.
Neurology|February 11, 2000
E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's diseaseJ Corey-Bloom, P Tiraboschi, L A Hansen, et al.
Neurology|February 11, 2000
Cholinergic dysfunction in diseases with Lewy bodiesP Tiraboschi, L A Hansen, M Alford, et al.
Neurology|April 17, 2008
Pathologic findings in prospectively ascertained essential tremor subjectsH A Shill, C H Adler, M N Sabbagh, et al.
Neurology|April 13, 2005
Smoking affects the phenotype of Alzheimer diseaseM N Sabbagh, S L Tyas, S C Emery, et al.
Dementia and Geriatric Cognitive Disorders|July 21, 2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's diseaseC G Schipke, O Peters, I Heuser, et al.
Pageof 4